What is Neuland Laboratories Ltd. Quarterly Revenue?

Neuland Laboratories Ltd. Quarterly Revenue Neuland Laboratories Jun-2026 Quarterly Revenue is Rs 650 Cr which is growth of 116.3% YoY.

What is Neuland Laboratories Ltd. Quarterly Net Profit?

Neuland Laboratories Ltd. Quarterly Net Profit Neuland Laboratories Jun-2026 Quarterly Net Profit is Rs 147 Cr which is growth of 975.0% YoY.

What is Neuland Laboratories Ltd. Annual Revenue?

Neuland Laboratories Ltd. Annual Revenue Neuland Laboratories Mar-2026 Annual Revenue is Rs 2,053 Cr which is growth of 37.1% YoY.

What is Neuland Laboratories Ltd. Annual Net Profit?

Neuland Laboratories Ltd. Annual Net Profit Neuland Laboratories Mar-2026 Annual Net Profit is Rs 363 Cr which is growth of 40.0% YoY.

What is Neuland Laboratories Ltd. Total Shareholders Fund?

Neuland Laboratories Ltd. Total Shareholders Fund Neuland Laboratories Mar-2026 Total Shareholders Fund is Rs 1,866 Cr which is growth of 22.9% YoY.

What is Neuland Laboratories Ltd. Total Assets?

Neuland Laboratories Ltd. Total Assets Neuland Laboratories Mar-2026 Total Assets is Rs 2,928 Cr which is growth of 34.4% YoY.

What is Neuland Laboratories Ltd. Book Value Per Share?

Neuland Laboratories Ltd. Book Value Per Share Neuland Laboratories Mar-2026 Book Value Per Share is 1,446 Rs which is growth of 22.9% YoY.

What is Neuland Laboratories Ltd. ROE?

Neuland Laboratories Ltd. ROE Neuland Laboratories Mar-2026 ROE is 19% which is growth of 2.4% YoY.

What is Neuland Laboratories Ltd. Cash From Operating Activity?

Neuland Laboratories Ltd. Cash From Operating Activity Neuland Laboratories Mar-2026 Cash From Operating Activity is Rs 348 Cr which is growth of 9.5% YoY.

What is Neuland Laboratories Ltd. Net Cash Flow?

Neuland Laboratories Ltd. Net Cash Flow Neuland Laboratories Mar-2026 Net Cash Flow is Rs -55 Cr which is growth of -224.5% YoY.

Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558

Mid-range Performer

Download real time

US FDA Inspections ANDA Approvals

-155.00(-0.76%)

75.70% Gain from 52W Low

11,935

NSE+BSE Volume

NSE 14 Oct, 2026 10:45 AM (IST)

Portfolio

Alert

My Notes

Neuland Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Neuland Laboratories share price target, revenues, EPS, net income and more

Neuland Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Neuland Laboratories Jun-2026 Quarterly Revenue is Rs 650 Cr which is growth of 116.3% YoY.
POSITIVE
Quarterly Net Profit Neuland Laboratories Jun-2026 Quarterly Net Profit is Rs 147 Cr which is growth of 975.0% YoY.

Neuland Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	650.1	788.7	447.8	516.1	300.6	335.8	401.9	315.2	444.4	390.4	394.9	420.8	365
SR_Q Operating Rev.	641.6	776.3	439.7	514.3	292.8	328.4	398	310.8	439.6	385	392.8	417.8	363
OI_Q Other Income	8.5	12.5	8.1	1.8	7.9	7.5	3.9	4.3	4.8	5.4	2.1	3.1	2
OEXPNS_Q Operating Exp.	419	469.4	362.8	359.2	258.5	277.6	311.7	249.5	315.8	278.2	272.3	280.5	265.7
OEXPNS_Q Operating Exp.	419	469.4	362.8	359.2	258.5	277.6	311.7	249.5	315.8	278.2	272.3	280.5	265.7
OP_Q Operating Profit	222.6	306.9	76.9	155.1	34.3	50.8	86.4	61.3	123.8	106.8	120.6	137.3	97.3
OPMPCT_Q Operating Profit Margin %	34.69%	39.54%	17.49%	30.16%	11.71%	15.46%	21.70%	19.73%	28.17%	27.74%	30.69%	32.87%	26.80%
DEP_Q Depr.	26.6	25.1	23.9	22.5	20.2	16.9	16.3	16.1	16.3	16.5	15.1	14.5	13.6
INT_Q Interest	7	7.2	6.8	5.3	4.6	2.4	2.2	1.1	2.7	3.6	3.7	4.4	2.2
PBT_Q Profit Before Tax	197.5	287	54.3	129	17.4	39	127.5	48.5	130.3	92.1	103.8	121.4	83.5
TAX_Q Tax	50.2	74.5	13.9	32.6	3.7	11.3	26.2	16.6	32	24.5	23.1	32.3	21.3
NP_Q Net Profit	147.4	212.5	40.4	96.5	13.7	27.7	101.4	32	98.3	67.6	80.7	89.1	62.2
EPS_adj_Q EPS Adj. latest	114.9	165.7	31.5	75.2	10.7	21.6	79	24.9	76.7	52.7	62.9	69.4	48.5
NP_TTM Net profit TTM	496.8	363.1	178.3	239.3	174.8	259.4	299.3	278.6	335.7	299.6	316.5	266.2	215.5
EPS_TTM Basic EPS TTM	385.1	281.5	138.2	185.5	135.5	201.1	232	216	260.2	232.2	245.3	206.4	167.1
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Neuland Laboratories competitor comparison and performance snapshot within industry

Neuland Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Neuland Laboratories Mar-2026 Annual Revenue is Rs 2,053 Cr which is growth of 37.1% YoY.
POSITIVE
Annual Net Profit Neuland Laboratories Mar-2026 Annual Net Profit is Rs 363 Cr which is growth of 40.0% YoY.

Neuland Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	19.6%	16.6%	2,402.6	2,053.2	1,497.4	1,571.1	1,201	953.2	953	766.6	670.3	531.9	580.1	511.6
TotalOperatingRevenues_A Operating Rev. Ann.	19.3%	16.6%	2,371.8	2,023	1,476.8	1,558.6	1,191.2	951.1	936.9	762.7	666.8	527.4	578.9	510
OI_A Other Income Ann.	45.5%	13.4%	30.8	30.2	20.5	12.5	9.8	2.1	16.1	3.9	3.5	4.5	1.2	1.6
OEXPNS_A Operating Exp. Ann.	16.4%	12.9%	1,610.3	1,449.7	1,154.5	1,096.7	919.9	808.9	790.5	661.3	609	477.4	473.2	430.1
OEXPNS_A Operating Exp. Ann.	16.4%	12.9%	1,610.3	1,449.7	1,154.5	1,096.7	919.9	808.9	790.5	661.3	609	477.4	473.2	430.1
OP_A Operating Profit Ann.	28.3%	31.4%	761.5	573.3	322.3	461.9	271.3	142.2	146.4	101.5	57.9	50	105.7	79.9
OPMPCT_A OPM Ann. %	7.3%	12.7%		27.92%	21.52%	29.40%	22.59%	14.92%	15.37%	13.23%	8.63%	9.41%	18.22%	15.61%
TotalExpenses_A Total Exp. Ann. ⌄	16.7%	13%		1,565.4	1,228.4	1,170.4	985.7	871.4	848.1	714.1	650.5	518.4	513.5	470.3
OtherExpenses_A Other Exp. Ann.	16%	14.6%	386.3	173.8	142.6	114.3	111.3	79.6	87.8	65	61.3	61.8	54.7	63.9
EmployeeBenefitExpenses_A Employee Exp. Ann.	19.1%	18%	361	328.8	261.4	248.5	194.8	175.8	144	118.5	104.5	95.7	84.9	50.2
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	29%	30%		603.4	342.8	474.5	281.1	144.3	162.5	105.3	61.4	54.6	106.9	81.5
EBIDTPCT_A EBITDA Ann. margin %	7.9%	11.5%		29.39%	22.89%	30.20%	23.40%	15.14%	17.06%	13.74%	9.15%	10.26%	18.42%	15.93%
INT_A Interest Ann.	22.4%	6%	26.3	24	8.3	14	13.1	13.5	17.9	21.6	15.7	18.9	21.1	24.5
DEP_A Depr.	20.2%	18.2%	98.1	91.7	65.5	59.7	52.8	49	39.7	31.3	25.9	22.1	19.2	15.7
PBT_A PBT Ann.	31.4%	36%	667.9	487.7	345.4	400.8	215.2	81.7	105	52.5	19.8	13.5	66.6	41.3
TAX_A Tax Ann.	33.7%	38.2%	171.1	124.6	86	101.2	52.1	18.2	24.7	36.6	3.7	1.7	20.2	14.9
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	30.6%	35.2%		363.1	259.4	299.6	163.1	63.5	80.3	15.9	16.1	11.8	46.4	26.4
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	30.6%	35.2%	496.8	363.1	259.4	299.6	163.1	63.5	80.3	15.9	16.1	11.8	46.4	26.4
NETPCT_A NPM Ann. %	9.4%	15.9%		17.94%	17.56%	19.22%	13.69%	6.68%	8.57%	2.08%	2.42%	2.23%	8.01%	5.17%
EPS_adj_A EPS Adj. latest Ann.	30.6%	35.2%		283	202.2	233.5	127.1	49.5	62.6	12.4	12.6	9.2	36.2	20.6
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

37.1%

2Y CAGR

14.3%

3Y CAGR

19.6%

5Y CAGR

16.6%

7Y CAGR

17.3%

10Y CAGR

14.9%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

40%

2Y CAGR

10.1%

3Y CAGR

30.6%

5Y CAGR

35.2%

7Y CAGR

56.1%

10Y CAGR

30%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

25.6%

2Y CAGR

15%

3Y CAGR

16.4%

5Y CAGR

12.9%

7Y CAGR

13.2%

10Y CAGR

12.9%

Operating Expenses Annual Cr growth is higher than historical averages.

Neuland Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Neuland Laboratories Mar-2026 Total Shareholders Fund is Rs 1,866 Cr which is growth of 22.9% YoY.
POSITIVE
Total Assets Neuland Laboratories Mar-2026 Total Assets is Rs 2,928 Cr which is growth of 34.4% YoY.

Neuland Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	23.6%	19%	1,865.9	1,517.8	1,276.5	988.4	835.6	781.9	705.6	695.6	243.9	231.9	184.2
EQCAP_A Equity Share Capital Ann.	0%	0%	12.9	12.9	12.9	12.9	12.9	12.9	12.9	12.9	9	9	9
TotalShareCapital_A Total Share Capital Ann.	0%	0%	12.9	12.9	12.9	12.9	12.9	12.9	12.9	12.9	9	9	9
ReservesAndSurplus_A Reserves Plus Surplus Ann.	23.9%	19.2%	1,852.1	1,504.1	1,262.8	974.6	821.8	768.1	691.8	681.8	235	223	174.4
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	23.8%	19.2%	1,853	1,504.9	1,263.6	975.5	822.7	769	692.6	682.7	235	223	175.2
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	33.2%	15.3%	343.2	187.5	120.6	145.2	178.4	168.7	162.2	103.1	145.8	53.8	69
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	5.6%	2.7%	67.4	71.6	59.3	57.3	11.5	59	47	10.4	12.1	14.6	14.2
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	194.6%	51.5%	99.7	18.6	9.2	3.9	62.7	12.5	25.7	20.3	20.3	0.2	2.5
CL_A Total Current Liabilities Ann. ⌄	17.3%	14%	719.2	472.8	433.8	445.8	368.1	373	362	331.2	370.4	288.2	270.2
TradePayables_A Trade Payables Ann.	16.1%	12.2%	278.7	260.9	198.5	178	117.5	156.8	120	126.6	129	88.6	83.5
OtherCurrentLiabilities_A Other Current Liabilities Ann.	22.5%	20.5%	402.6	164.6	196	219	122.7	158.6	71.6	54.7	40.6	47.1	57.5
ShortTermProvisions_A ST Provisions Ann.	15.3%	30.8%	2.3	2.1	1.6	1.5	1.2	0.6	2.3	0.8	1.6	1.4	5.5
TL_A Total Capital Plus Liabilities Ann.	22.9%	17.2%	2,928.3	2,178.2	1,830.9	1,579.3	1,382.1	1,323.5	1,229.7	1,129.9	1,070.9	884.9	523.3
FixedAssets_A Fixed Assets Ann. ⌄	20.2%	13.6%	1,387.5	1,002.6	869.6	798.1	787.8	733.1	676.3	646	600.9	485.2	179.3
TangibleAssets_A Tangible Assets Ann.	25%	16.6%	892.3	673.7	522.7	457.4	466.1	414	341.3	230.4	163.8	155	138.3
IntangibleAssets_A Intangible Assets Ann.	0.4%	0.1%	284.6	281.2	281.9	280.8	281.6	283	281.4	281.3	281.3	280.8	0.5
CapitalWorkInProgress_A Capital Work In Progress Ann.	72.8%	64.7%	209.5	44.6	45.9	40.6	20.5	17.3	23.8	104.5	126.1	19.6	40.5
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	20.9%	13.3%	1,447	1,040.4	911.5	819	800.9	775.3	715.9	677	624.2	510.6	210
NonCurrentInvestments_A Non Current Investments Ann.	44.2%	28.5%	2.1	1.7	1.4	0.7	0.7	0.6	0.5	0.6	0.6	0.5	7.6
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-								3.1	3	3.1	23.2
OtherNonCurrentAssets_A Other Non Current Assets Ann.	41.6%	6.6%	57.3	36.1	40.5	20.2	12.4	41.7	39.1	27.4	19.7	21.9
CA_A Total Current Assets Ann. ⌄	24.9%	22%	1,481.4	1,137.8	919.5	760.3	581.2	548.2	513.8	452.9	446.7	374.2	313.3
CurrentInvestments_A Current Investments Ann.	216.4%	70.4%		107.7			3.4	6.5	7.5	7.5	7.5	7.5
TradeReceivables_A Trade Receivables Ann.	14.4%	20%	541.4	315.7	373.5	361.8	234.3	217.7	189.9	164	193.9	181.1	119.1
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	82%	81.2%	353.6	257.3	115.3	58.7	19	18.1	45.7	37.4	17.1	12	9
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-											49.6
OtherCurrentAssets_A Other Current Assets Ann.	7.8%	5.5%	76.1	71.4	80.2	60.7	59.3	58.3	51.2	51.4	53.2	38.5	8.9
TA_A Total Assets Ann.	22.9%	17.2%	2,928.3	2,178.2	1,830.9	1,579.3	1,382.1	1,323.5	1,229.7	1,129.9	1,070.9	884.9	523.3
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	18.5%	5.6%	167.4	92.2	140.5	100.7	93	127.5	134.7	24.1	9.5		30.8
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	73.8%	39.3%	2.1	1.7	1.4	0.4	0.4	0.4	0.4	0.6	0.6	0.5	7.5
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	208.7%	67.9%		100			3.4	6.5	7.5	7.5	7.5	7.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

34.4%

2Y CAGR

26.5%

3Y CAGR

22.9%

5Y CAGR

17.2%

7Y CAGR

14.6%

10Y CAGR

18.8%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

52.1%

2Y CAGR

28.8%

3Y CAGR

17.3%

5Y CAGR

14%

7Y CAGR

11.7%

10Y CAGR

10.3%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

22.9%

2Y CAGR

20.9%

3Y CAGR

23.6%

5Y CAGR

19%

7Y CAGR

15.1%

10Y CAGR

26.1%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Neuland Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Neuland Laboratories Mar-2026 Book Value Per Share is 1,446 Rs which is growth of 22.9% YoY.
POSITIVE
ROE Neuland Laboratories Mar-2026 ROE is 19% which is growth of 2.4% YoY.

Neuland Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	23.6%	19%	1,445.7	1,175.9	988.9	765.5	647.1	605.4	546.3	538.5	272.4	259	204.8
ROA_A RoA Ann. %	6.3%	15.4%	12.39%	11.91%	16.36%	10.32%	4.59%	6.06%	1.29%	1.42%	1.10%	5.24%	5.04%
ROE_A ROE Ann. %	5.6%	13.6%	19.46%	17.10%	23.48%	16.51%	7.61%	10.28%	2.25%	2.32%	4.84%	19.99%	14.40%
ROCE_A ROCE Ann. %	4.8%	12.4%	23.16%	16.25%	29.68%	20.13%	9.39%	12.92%	8.53%	4.44%	4.63%	14.68%	25.96%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	8.1%	11.5%	29.82%	23.21%	30.44%	23.59%	15.16%	17.34%	13.81%	9.20%	10.34%	18.45%	15.97%
PBITMargin_A EBIT Ann. Margin %	9.7%	14%	25.29%	18.77%	26.61%	19.16%	10.01%	13.11%	9.71%	5.32%	6.15%	15.13%	12.89%
PBTMargin_A PBT Ann. Margin %	10.1%	16.6%	24.10%	23.38%	25.71%	18.06%	8.59%	11.20%	6.88%	2.97%	2.56%	11.49%	8.09%
NETPCT_A NPM Ann. %	9.4%	15.9%	17.94%	17.56%	19.22%	13.69%	6.68%	8.57%	2.08%	2.42%	2.23%	8.01%	5.17%
ASETTO_A Asset Turnover Ann. %	0%	2.7%	0.8	0.7	0.9	0.8	0.7	0.7	0.7	0.6	0.5	0.8	1
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	7.3%	7%	2.1	2.4	2.1	1.7	1.6	1.5	1.4	1.4	1.2	1.3	1.2
QuickRatio_A Quick Ratio Ann.	8.4%	11.8%	1.4	1.6	1.3	1.1	0.9	0.8	0.8	0.8	0.7	0.8	0.7
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	0	0.1	0	0	0.1	0	0.3			0.1	0.1
EarningRetention_A Earning Retention Ann. %	-0.1%	-0.2%	95.76%	93.08%	95.72%	96.07%	93.95%	96.81%	68.84%			98.15%	93.28%
CashEarningRetention_A Cash Earning Retention Ann. %	-0.1%	-0.3%	96.62%	94.48%	96.43%	97.03%	96.59%	97.87%	89.51%			98.70%	95.79%
CashEarningRetention_A Cash Earning Retention Ann. %	-0.1%	-0.3%	96.62%	94.48%	96.43%	97.03%	96.59%	97.87%	89.51%			98.70%	95.79%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	86%	40.3%	15,339.9	15,458.6	8,070.4	2,384.2	1,536.3	2,820.6	565.5	1,042.4	918.8	1,501.5	786.8
EVPerNetSales_A EV Per Net Sales Ann.	56%	20.4%	7.6	10.5	5.2	2	1.6	3	0.7	1.6	1.7	2.6	1.5
PBV_A Price To Book Value Adjusted	-19.4%	-16.2%	13.89	18.67	20.54	26.54	31.4	33.56	37.19	37.72	74.76	78.63	99.46
EVPerEBITDA_A EV Per EBITDA Ann.	44%	7.9%	25.4	45.1	17	8.5	10.7	17.4	5.4	17	16.8	14.1	9.7
MarketCapPerSales_A Market Cap Per Sales Ann.	56.7%	21.6%	7.7	10.6	5.2	2	1.4	2.9	0.5	1.3	1.2	2.3	1.2
RetentionRatios_A Retention Ratio Ann. %	-0.1%	-0.2%	95.75%	93.07%	95.71%	96.06%	93.94%	96.80%	68.83%			98.14%	93.27%
EYield_A Earnings Yield Ann.	-	-	0	0	0	0.1	0.1	0	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.	0%	-12.9%	0.1	0.1	0.1	0.1	0.3	0.2	0.4	0.3	1.2	0.8	0.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

13.8%

2Y CAGR

-9%

3Y CAGR

5.6%

5Y CAGR

13.6%

7Y CAGR

35.5%

10Y CAGR

3.1%

ROE Annual % is stable compared to historical averages.

RoA Ann. %

1Y CHG

2Y CAGR

-13%

3Y CAGR

6.3%

5Y CAGR

15.4%

7Y CAGR

36.3%

10Y CAGR

9.4%

RoA Annual % is growing slower than historical averages.

Current Ratio Ann.

1Y CHG

-12.5%

3Y CAGR

7.3%

5Y CAGR

7Y CAGR

10Y CAGR

5.8%

Current Ratio Annual is falling faster than historical averages.

Neuland Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Neuland Laboratories Mar-2026 Cash From Operating Activity is Rs 348 Cr which is growth of 9.5% YoY.
NEGATIVE
Net Cash Flow Neuland Laboratories Mar-2026 Net Cash Flow is Rs -55 Cr which is growth of -224.5% YoY.

Neuland Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	13.4%	12.9%	347.6	317.5	260.1	238.5	58.6	189.3	56.6	69.6	11.5	38.9	44.7
PBT_A PBT Ann.	31.4%	36%	487.7	345.4	400.8	215.2	81.7	105	52.5	19.8	13.5	66.6	41.3
INT_A Interest Ann.	22.4%	6%	24	8.3	14	13.1	13.5	17.9	21.6	15.7	18.9	21.1	24.5
TAX_A Tax Ann.	33.7%	38.2%	124.6	86	101.2	52.1	18.2	24.7	36.6	3.7	1.7	20.2	14.9
CFI_A Cash from Investing Act. Ann.	-	-	-423.7	-298.1	-149.7	-61.5	-93.7	-84.4	-48.7	-77.2	-116.3	-42.1	-19.9
CFA_A Cash from Financing Act. Ann.	-	-	21	25	-69.3	-135.8	37.7	-113.7	-5.5	12	104.9	-0.1	-23.6
NCF_A Net Cash Flow Ann. ⌄	-	-	-55.2	44.3	41.1	41.2	2.6	-8.8	2.5	4.4	0.1	-3.3	1.2
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	227.9%	67.5%	130.4	86.1	45	3.7	1.1	9.9	7.4	3.1	3	6.3	0.3
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	18.7%	132.9%	75.3	130.4	86.1	45	3.7	1.1	9.9	7.4	3.1	3	1.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

9.5%

2Y CAGR

15.6%

3Y CAGR

13.4%

5Y CAGR

12.9%

7Y CAGR

25.8%

10Y CAGR

22.8%

Cash from Operating Activity Annual growth is lower than historical averages.

Cash from Financing Act. Ann.

1Y CHG

-16%

7Y CAGR

8.3%

Cash from Financing Annual Activity is falling faster than historical averages.

Neuland Laboratories investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

75.70% Gain from 52W Low

Neuland Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Neuland Laboratories - Forecaster

Forecaster Analyst Estimates for Neuland Laboratories share price target, revenues, EPS, net income and more